Composites Part B Engineering, Journal Year: 2024, Volume and Issue: 291, P. 111976 - 111976
Published: Nov. 16, 2024
Language: Английский
Composites Part B Engineering, Journal Year: 2024, Volume and Issue: 291, P. 111976 - 111976
Published: Nov. 16, 2024
Language: Английский
Composites Part B Engineering, Journal Year: 2025, Volume and Issue: unknown, P. 112163 - 112163
Published: Jan. 1, 2025
Language: Английский
Citations
1Composites Part B Engineering, Journal Year: 2025, Volume and Issue: unknown, P. 112192 - 112192
Published: Feb. 1, 2025
Language: Английский
Citations
1Composites Part B Engineering, Journal Year: 2024, Volume and Issue: 291, P. 111970 - 111970
Published: Nov. 12, 2024
Language: Английский
Citations
5Composites Part B Engineering, Journal Year: 2024, Volume and Issue: 280, P. 111481 - 111481
Published: April 24, 2024
With the increasing incidence of osteoarthritis (OA) in elderly patients and challenges posed by its multifaceted pathogenesis developing effective treatments, this study explores protein loading mode Progranulin (PGRN) therapeutic potential for treating OA. GelMA hydrogels prepared with different concentrations PGRN, employing AC-PEG-NHS as a crosslinking agent drug encapsulation, were used to test sustained release effect composite hydrogel delivery system. Additionally, we conducted vitro assays investigate regulatory effects on rat bone marrow mesenchymal atromal cells (BMSCs), chondrocytes, mouse macrophages - focusing cell proliferation, differentiation. For vivo studies, histological staining techniques utilized assess inflammatory polarization cartilage repair knee injury model. The results demonstrated that PGRN-loaded significantly accelerated enhance differentiation BMSCs into maintained healthy chondrocyte phenotype, induce M2-type while inhibiting M1-type macrophages. Histological analyses also showed markedly improved tissue group treated GelMA–NHS–PGRN hydrogels. As result, these present promising approach OA, potentially mitigating chronic inflammation facilitating through controlled PGRN. Osteoarthritis, Anti-inflammatory hydrogels, Cartilage regeneration.
Language: Английский
Citations
4Materials Today Bio, Journal Year: 2025, Volume and Issue: 31, P. 101494 - 101494
Published: Jan. 13, 2025
Osteochondral defects are still facing a significant challenge in clinical surgery, making post-trauma repair difficult. Tissue engineering has provided promising approach to solving these defects. However, existing scaffolds cannot replicate the complex biphasic cartilage-bone microenvironment with accuracy. We aimed develop biomimetic scaffold regionally regulated vascularization that promoted chondrogenesis and osteogenesis through bidirectional regulation of endochondral ossification. This consisted pre-chondrogenic microspheres (PCMs) decalcified bone frame prepared by decalcifying cartilage layer varying degrees. Incorporation PCMs into created regeneration while axitinib was modified inhibit enhance regeneration. The ossification facilitated repair. In vitro studies have shown axitinib-modified layers significantly VEGF expression cells, powder from promotes PCMs. vivo experiments indicated this controls regionalized angiogenesis, promoting integrated reconstruction osteochondral rabbit knee joints. These results suggest our designed demineralized can precisely engineer microenvironment, providing theoretical guidance for anisotropic tissue injuries.
Language: Английский
Citations
0Biomaterials Science, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
Cartilage tissue engineering based on the combination of biomaterials, adult or stem cells and bioactive factors is a challenging approach for regenerative medicine with aim achieving formation functional neotissue stable in long term. Various 3D scaffolds have been developed to mimic extracellular matrix environment promote cartilage repair. In addition, extensively employed induce maintain phenotype. However, spatiotemporal control factor release remains critical maximizing potential multipotent cells, such as mesenchymal stromal (MSCs), efficient chondrogenesis sustained homeostasis, which are essential repair hyaline cartilage. Despite advances, effective delivery limited by challenges insufficient retention at site injury loss therapeutic efficacy due uncontrolled drug release. These limitations prompted research biomolecule-scaffold interactions develop advanced systems that provide controlled bioavailability biological factors, thereby improving outcomes. This review focuses specifically biomaterials (natural, hybrid synthetic) biomolecules (molecules, proteins, nucleic acids) interest engineering. Herein, we detail approaches their release, chemical nature structure, through steric, non-covalent and/or covalent interactions, view application
Language: Английский
Citations
0Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: unknown, P. 162441 - 162441
Published: April 1, 2025
Language: Английский
Citations
0Composites Part B Engineering, Journal Year: 2024, Volume and Issue: 291, P. 111976 - 111976
Published: Nov. 16, 2024
Language: Английский
Citations
2